Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

137.19
Delayed Data
As of 3:59pm ET
 +3.63 / +2.72%
Today’s Change
75.52
Today|||52-Week Range
153.15
+36.82%
Year-to-Date

Today’s Trading

Previous close133.56
Today’s open133.52
Day’s range132.70 - 137.90
Volume893,607
Average volume (3 months)1,853,510
Market cap$27.3B
Dividend yield--
Data as of 3:59pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-238.53%
Earnings growth (next 5 years)+98.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book60.13

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.72+1.33%
ZTSZoetis Inc+0.78+1.27%
BAXBaxter International...-0.87-1.40%
MYLMylan NV+0.37+0.95%
Data as of 4:01pm ET, 07/26/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts